P

Inventor

SUN PIAOYANG

CN43 patents
⚠️ This page may combine multiple inventors who share the name “SUN PIAOYANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

JIANGSU HENGRUI MEDICINE CO

18 patents
US10905743B2Feb 2, 2021

Interleukin 15 protein complex

JIANGSU HENGRUI MEDICINE CO9 citations85
US10150770B2Dec 11, 2018

Crystal form of bisulfate of JAK inhibitor and preparation method therefor

JIANGSU HENGRUI MEDICINE CO6 citations82
US9422300B2Aug 23, 2016

Bisulfate of janus kinase (JAK) inhibitor and preparation method therefor

JIANGSU HENGRUI MEDICINE CO9 citations82
US10023577B2Jul 17, 2018

Crystalline form of JAK kinase inhibitor bisulfate and a preparation method thereof

JIANGSU HENGRUI MEDICINE CO6 citations81
US10364234B2Jul 30, 2019

Pyridinecarboxamide derivatives, preparation method thereof and pharmaceutical uses thereof

JIANGSU HENGRUI MEDICINE CO1 citations73
US11717559B2Aug 8, 2023

Interleukin 15 protein complex and use thereof

JIANGSU HENGRUI MEDICINE CO2 citations72
US9309226B2Apr 12, 2016

Crystalline form I of tyrosine kinase inhibitor dimaleate and preparation methods thereof

JIANGSU HENGRUI MEDICINE CO3 citations72
US10442793B2Oct 15, 2019

Oxa spiro derivative, preparation method therefor, and applications thereof in medicines

JIANGSU HENGRUI MEDICINE CO2 citations70
US11981733B2May 14, 2024

LAG-3 antibody, antigen-binding fragment thereof, and pharmaceutical application thereof

JIANGSU HENGRUI MEDICINE CO0 citations60
US11155617B2Oct 26, 2021

LAG-3 antibody, antigen-binding fragment thereof, and pharmaceutical application thereof

JIANGSU HENGRUI MEDICINE CO0 citations60
US11000518B2May 11, 2021

Use of combination of VEGFR inhibitor and PARP inhibitor in preparation of medicament for treating gastric cancer

JIANGSU HENGRUI MEDICINE CO0 citations57
US8362256B2Jan 29, 2013

Salts of N-[4-(1-cyanocyclopentyl)phenyl]-2-(4-pyridylmethyl)amino-3-pyridinecarboxamide

JIANGSU HENGRUI MEDICINE CO3 citations55
US10759788B2Sep 1, 2020

Pharmaceutical uses of pyridine carboxamide derivatives

JIANGSU HENGRUI MEDICINE CO0 citations52
US10442794B2Oct 15, 2019

Processes for preparing pyridine carboxamide derivatives

JIANGSU HENGRUI MEDICINE CO0 citations52
US10793643B2Oct 6, 2020

PCSK9 antibody, antigen-binding fragment thereof, and medical application thereof

JIANGSU HENGRUI MEDICINE CO0 citations49
US10857146B2Dec 8, 2020

Method for preventing or treating tumor diseases with a combination of tyrosine kinase inhibitor and CDK4/6 inhibitor

JIANGSU HENGRUI MEDICINE CO0 citations48
US10301344B2May 28, 2019

L-proline complex of sodium-glucose cotransporter 2 inhibitor, monohydrate and crystal form thereof

JIANGSU HENGRUI MEDICINE CO0 citations46
US10398689B2Sep 3, 2019

Benzopiperidine derivative, preparation method thereof and medical use thereof

JIANGSU HENGRUI MEDICINE CO0 citations39

Shanghai hengrui pharmaceutical co ltd

9 patents

SUN PIAOYANG

5 patents

SUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD

3 patents

JIANGSU HANSOH PHARMACEUTICAL CO LTD

1 patent

TANG PENG CHO

1 patent

MEDIVIR AB

1 patent

ZHANG FUYAO

1 patent

SHANGHAI HENGRUI PHARM CO LTD

1 patent

YUAN KAIHONG

1 patent

WALLBERG HANS

1 patent

SHANGHAI SENHUI MEDICINE CO LTD

1 patent